TIFF Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-28,244
Closed -$505K 6
2017
Q3
$505K Buy
+28,244
New +$505K 0.32% 8